Mellozzan (Melatonin)

Melatonin in Mellozzan binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. This interaction signals darkness to the body, helping to synchronize the internal clock, reduce alertness, and promote the onset of sleep.

The appropriate dose of Mellozzan is determined by the prescribing healthcare professional based on the individual’s age, condition and response. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for melatonin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mellozzan.

To order Mellozzan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike many prescription hypnotics, melatonin works by mimicking a natural hormone rather than depressing central nervous system activity. This generally results in a lower risk of dependence, but its efficacy may be more modest and is best suited for sleep problems linked to circadian rhythm disturbances.

Mellozzan should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency.

Mellozzan is taken orally, usually with a glass of water. It is commonly taken 30‑60 minutes before bedtime, but the exact timing should follow the prescriber’s guidance.

Serious risks, though rare, include severe allergic reactions such as rash, swelling or difficulty breathing, and hormonal disturbances that may affect menstrual cycles or mood. Any signs of an allergic response or unexpected psychological changes should prompt immediate medical attention.

Individuals with known hypersensitivity to melatonin, those taking certain anticoagulants or immunosuppressants without medical supervision, and patients with uncontrolled epilepsy or severe depression should avoid using Mellozzan unless directed by a qualified healthcare professional.